4//SEC Filing
SCICLONE PHARMACEUTICALS INC 4
Accession 0001181431-13-046422
CIK 0000880771operating
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 1:18 PM ET
Size
12.4 KB
Accession
0001181431-13-046422
Insider Transaction Report
Form 4
Yin Min
See Remarks
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-08-22−10,938→ 14,062 totalExercise: $4.21Exp: 2021-10-31→ Common Stock (10,938 underlying) - Exercise/Conversion
Common Stock
2013-08-22$4.21/sh+10,938$46,049→ 10,938 total - Sale
Common Stock
2013-08-22$5.50/sh−10,938$60,159→ 0 total
Footnotes (2)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]25% of such shares vest one year from the grant date of October 31, 2011, and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 1:18 PM ET
- Size
- 12.4 KB